{"filing":{"accession_number":"0001104659-26-089220","cik":"0001130598","ticker":"TRAW","company_name":"Traws Pharma, Inc.","form":"8-K","filing_date":"2026-07-31","report_date":"2026-07-29","primary_document":"tm2621656d1_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1130598/000110465926089220/tm2621656d1_8k.htm"},"events":[{"id":22402,"run_id":20265,"accession_number":"0001104659-26-089220","anchor_item_number":"3.01","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.98,"summary":"Traws Pharma received a notification from Nasdaq on July 29, 2026, that it failed to meet the minimum bid price requirement (closing bid below $1.00 per share for 30+ consecutive business days) under Nasdaq Listing Rule 5550(a)(2). The company has 180 days until January 25, 2027, to regain compliance or face delisting. This is a classic delisting-risk disclosure under Item 3.01, materially affecting investor assessment of the company's continued public listing status.","company_name":"Traws Pharma, Inc.","ticker":"TRAW","filing_date":"2026-07-31","form":"8-K","submitted_at":null,"items":[{"id":22330,"accession_number":"0001104659-26-089220","item_number":"3.01","item_title":"Notice of Delisting or Failure to Satisfy a Continued","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.98,"reasoning":"Traws Pharma received a notification from Nasdaq on July 29, 2026, that it failed to meet the minimum bid price requirement (closing bid below $1.00 per share for 30+ consecutive business days) under Nasdaq Listing Rule 5550(a)(2). The company has 180 days until January 25, 2027, to regain compliance or face delisting. This is a classic delisting-risk disclosure under Item 3.01, materially affecting investor assessment of the company's continued public listing status.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-01T00:13:35.990833+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":22330,"accession_number":"0001104659-26-089220","item_number":"3.01","item_title":"Notice of Delisting or Failure to Satisfy a Continued","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.98,"reasoning":"Traws Pharma received a notification from Nasdaq on July 29, 2026, that it failed to meet the minimum bid price requirement (closing bid below $1.00 per share for 30+ consecutive business days) under Nasdaq Listing Rule 5550(a)(2). The company has 180 days until January 25, 2027, to regain compliance or face delisting. This is a classic delisting-risk disclosure under Item 3.01, materially affecting investor assessment of the company's continued public listing status.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-01T00:13:35.990833+00:00","company_name":"Traws Pharma, Inc.","ticker":"TRAW","filing_date":"2026-07-31"}]}